• On 27 June 2026, Helmerich & Payne, Inc. (NYSE:HP) was added to several Russell growth indices, including the Russell 2000, 2500, 3000, 3000E, and Small Cap Comp Growth benchmarks.
• This broad inclusion across multiple Russell growth benchmarks can increase the company’s visibility with institutional investors and may influence how its growth profile is assessed.
• Next, we will examine how Helmerich & Payne’s addition to multiple Russell growth indices interacts with its existing investment narrative.

The latest GPUs need a type of rare earth metal called Neodymium and there are only 30 companies in the world exploring or producing it. Find the list for free.

Helmerich & Payne Investment Narrative Recap

To own Helmerich & Payne, you need to believe that high spec drilling technology, international expansion and disciplined capital allocation can eventually translate into sustainable profitability despite current losses and sector volatility. The broad addition to Russell growth indices may raise the stock’s profile but does not materially change the near term focus on turning recent net losses and integration costs into healthier margins, or the key risk of ongoing capital intensity and demand uncertainty in North American shale activity.

Among recent announcements, the appointment of Trey Adams as President and CEO and the upcoming CFO transition stand out in light of the Russell index inclusions. A relatively new leadership team now faces greater visibility among institutional investors while working through unprofitable recent quarters and integrating KCAD, so how effectively management balances capital spending, debt obligations and international growth will be central to whether the current investment narrative holds up.

Yet despite the index additions, investors still need to weigh the risk that rising costs and drilling overcapacity could eventually challenge...

Helmerich & Payne's narrative projects $4.2 billion revenue and $228.7 million earnings by 2029. This assumes relatively flat yearly revenue growth and a roughly $545 million earnings increase from -$316.3 million today.

Uncover how Helmerich & Payne's forecasts yield a $38.40 fair value, a 14% upside to its current price.

Exploring Other Perspectives

By contrast, the most pessimistic analysts remind you that outcomes can differ widely, even as they still expected around US$4.0 billion of revenue and US$319.1 million of earnings by 2029.

Explore 3 other fair value estimates on Helmerich & Payne - why the stock might be worth just $38.40!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Helmerich & Payne research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Helmerich & Payne research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Helmerich & Payne's overall financial health at a glance.

Interested In Other Possibilities?

Our top stock finds are flying under the radar-for now. Get in early:

• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Find 44 companies with promising cash flow potential yet trading below their fair value.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.